Litcius/Paper detail

Cu(<scp>ii</scp>) and V(<scp>iv</scp>)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-<scp>l</scp>-alanines reveal promising anticancer therapeutic potential

Nádia Ribeiro, İpek Bulut, Buse Cevatemre, Carlos M. Teixeira, Yasemin Yıldızhan, Vânia André, Pedro Adão, João Costa Pessoa, Ceyda Açılan, Isabel Correia

2020Dalton Transactions28 citationsDOI

Abstract

O)] (8) were further evaluated and their mechanism of action was determined to be apoptosis, evidenced by AnnexinV staining and the increase in caspase 3/7 activity. Compounds 3, 7 and 8 also exhibit DNA cleavage activity, involving the formation of reactive oxygen species and were able to induce genomic damage in cells as determined by COMET assay.

Topics & Concepts

ChemistryStereochemistryCombinatorial chemistryMetal complexes synthesis and propertiesMetal-Catalyzed Oxygenation MechanismsVanadium and Halogenation Chemistry
Cu(<scp>ii</scp>) and V(<scp>iv</scp>)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-<scp>l</scp>-alanines reveal promising anticancer therapeutic potential | Litcius